Skip to main content
Journal cover image

Can Innovation in Regulatory Science Address Health Care Cost Burdens?

Publication ,  Journal Article
Daniel, GW; Romine, MH; McClellan, MB
Published in: Clinical pharmacology and therapeutics
April 2019

Duke Scholars

Published In

Clinical pharmacology and therapeutics

DOI

EISSN

1532-6535

ISSN

0009-9236

Publication Date

April 2019

Volume

105

Issue

4

Start / End Page

809 / 811

Related Subject Headings

  • Pharmacology & Pharmacy
  • Organizational Innovation
  • Humans
  • Health Care Costs
  • Equipment and Supplies
  • Drug Industry
  • Drug Development
  • Diffusion of Innovation
  • Delivery of Health Care
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Daniel, G. W., Romine, M. H., & McClellan, M. B. (2019). Can Innovation in Regulatory Science Address Health Care Cost Burdens? Clinical Pharmacology and Therapeutics, 105(4), 809–811. https://doi.org/10.1002/cpt.1334
Daniel, Gregory W., Morgan H. Romine, and Mark B. McClellan. “Can Innovation in Regulatory Science Address Health Care Cost Burdens?Clinical Pharmacology and Therapeutics 105, no. 4 (April 2019): 809–11. https://doi.org/10.1002/cpt.1334.
Daniel GW, Romine MH, McClellan MB. Can Innovation in Regulatory Science Address Health Care Cost Burdens? Clinical pharmacology and therapeutics. 2019 Apr;105(4):809–11.
Daniel, Gregory W., et al. “Can Innovation in Regulatory Science Address Health Care Cost Burdens?Clinical Pharmacology and Therapeutics, vol. 105, no. 4, Apr. 2019, pp. 809–11. Epmc, doi:10.1002/cpt.1334.
Daniel GW, Romine MH, McClellan MB. Can Innovation in Regulatory Science Address Health Care Cost Burdens? Clinical pharmacology and therapeutics. 2019 Apr;105(4):809–811.
Journal cover image

Published In

Clinical pharmacology and therapeutics

DOI

EISSN

1532-6535

ISSN

0009-9236

Publication Date

April 2019

Volume

105

Issue

4

Start / End Page

809 / 811

Related Subject Headings

  • Pharmacology & Pharmacy
  • Organizational Innovation
  • Humans
  • Health Care Costs
  • Equipment and Supplies
  • Drug Industry
  • Drug Development
  • Diffusion of Innovation
  • Delivery of Health Care
  • 3214 Pharmacology and pharmaceutical sciences